![Mardi Dier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mardi Dier
Directeur Financier/CFO chez
MADRIGAL PHARMACEUTICALS, INC.
Fortune : 39 200 $ au 31/05/2026
Profil
Mme Mardi C. Dier est directrice financière et vice-présidente exécutive d'Ultragenyx Pharmaceutical, Inc. et directrice indépendante d'Oric Pharmaceuticals, Inc. et d'Adamas Pharmaceuticals, Inc. Elle siège aux conseils d'administration de Prelude Therapeutics, Inc. et d'Oric Pharmaceuticals, Inc. et d'Adamas Pharmaceuticals, Inc. Mme Dier a été précédemment employée en tant que directrice financière, directrice des affaires et vice-présidente exécutive chez Portola Pharmaceuticals, Inc. et vice-présidente des relations avec les investisseurs chez Chiron Corp, directrice des services bancaires d'investissement chez Prudential Equity Group LLC, comptable principale chez KPMG LLP, comptable principale chez KPMG Peat Marwick LLP et directrice des services bancaires d'investissement chez Prudential Securities. Elle a également été membre du conseil d'administration de Jewish Vocational Service, Inc. et de Futures Strategic Trust. Elle a obtenu son diplôme de premier cycle à l'université de Stanford et un MBA à l'UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2025 | 10 000 ( 0,02 % ) | 39 200 $ | 31/05/2026 | |
| 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Mardi Dier
| Sociétés | Poste | Début |
|---|---|---|
| ORIC PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/02/2020 |
| MADRIGAL PHARMACEUTICALS, INC. | Directeur Financier/CFO | 11/03/2024 |
Healthcare Royalty Management LLC
 Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Consultant / Advisor | - |
Synthekine, Inc.
 Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Directeur/Membre du Conseil | 03/06/2021 |
Anciens postes connus de Mardi Dier
| Sociétés | Poste | Fin |
|---|---|---|
| PRELUDE THERAPEUTICS INCORPORATED | Directeur/Membre du Conseil | 17/10/2025 |
| ACELYRIN, INC. | Directeur Financier/CFO | 02/08/2023 |
| ULTRAGENYX PHARMACEUTICAL INC. | Directeur Financier/CFO | 15/11/2022 |
| ADAMAS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 09/06/2021 |
| PORTOLA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/07/2020 |
Formation de Mardi Dier
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Futures Strategic Trust
 Futures Strategic Trust Investment Banks/BrokersFinance Invests in commodities contracts | Finance |
Prudential Securities
 Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets therapeutics for neurological diseases | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KPMG Peat Marwick LLP
 KPMG Peat Marwick LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Prudential Equity Group LLC
 Prudential Equity Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Healthcare Royalty Management LLC
Healthcare Royalty Management LLC Investment ManagersFinance Healthcare Royalty invests in companies located in the United States. The firm targets companies operating in the field of biopharmaceutical, biotechnology and medical device sectors. It provides financing for buyout transactions in the form of royalty monetization, corporate financing and debt. | Finance |
Jewish Vocational Service, Inc.
 Jewish Vocational Service, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a organization that provides adult education and workforce development services | Commercial Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oric Pharmaceuticals, Inc.
 Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Prelude Therapeutics, Inc.
 Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases | Health Technology |
Madrigal Pharmaceuticals, Inc.
 Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Synthekine, Inc.
Synthekine, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
